These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35262233)

  • 21. Vitiligo-like depigmentation with perifollicular pigment retention in systemic sclerosis treated successfully with suplatast tosilate.
    Fujimoto N; Hamaguchi Y; Tanaka T
    Eur J Dermatol; 2016; 26(1):110-2. PubMed ID: 26841835
    [No Abstract]   [Full Text] [Related]  

  • 22. ["Salt and pepper" sign in systemic sclerosis].
    Krauß M; Kreuter A; Matull J
    Dermatologie (Heidelb); 2024 Feb; 75(2):147. PubMed ID: 38189828
    [No Abstract]   [Full Text] [Related]  

  • 23. Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.
    Sharma NL; Mahajan VK; Ranjan N; Sharma VC; Gupta M
    Clin Rheumatol; 2010 Feb; 29(2):215-9. PubMed ID: 19834761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raynaud phenomenon and the vascular disease in scleroderma.
    Kahaleh MB
    Curr Opin Rheumatol; 2004 Nov; 16(6):718-22. PubMed ID: 15577610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic sclerosis: Current concepts of skin and systemic manifestations.
    Pearson DR; Werth VP; Pappas-Taffer L
    Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic sclerosis in Hispanics: cutaneous salt and pepper lesions.
    Ocampo-Candiani J; Suro-Santos Y; Villarreal-Martinez A; Herz-Ruelas ME; Galarza-Delgado DA; Hernandez-Galarza IJ; Villareal-Alarcon MA; Flores-Alvarado DE; Gomez-Flores M; Vazquez-Martinez OT; Chavez-Alvarez S
    Int J Dermatol; 2022 Mar; 61(3):e94-e96. PubMed ID: 34599598
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma.
    Cappelli L; Wigley FM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trigeminus neuropathy as a rare main symptom of progressive systemic sclerosis].
    Brunner U; Wagenhäuser FJ; Baumgartner G; Eichmann A
    Schweiz Med Wochenschr; 1988 Feb; 118(6):213-7. PubMed ID: 3259011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of eosinophilia in progressive systemic sclerosis and localized scleroderma.
    Giordano M; Ara M; Valentini G; Chianese U; Bencivenga T
    Arch Dermatol Res; 1981; 271(4):411-7. PubMed ID: 7332350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic Sclerosis Sine Scleroderma in Mexican Patients. Case Reports.
    Vera-Lastra O; Sauceda-Casas CA; Domínguez MDPC; Alvarez SAM; Sepulceda-Delgado J
    Reumatol Clin (Engl Ed); 2018; 14(4):230-232. PubMed ID: 28065485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic sclerosis (scleroderma). Clinical management of its major complications.
    Legerton CW; Smith EA; Silver RM
    Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy in women with systemic sclerosis.
    Steen VD
    Obstet Gynecol; 1999 Jul; 94(1):15-20. PubMed ID: 10389711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of oesophageal mucosal folds in systemic sclerosis.
    Owen JP; Muston HL; Goolamali SK
    Clin Radiol; 1979 Sep; 30(5):489-92. PubMed ID: 466950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
    Lomeo RM; Cornella RJ; Schabel SI; Silver RM
    Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What kind of durometer is best suited for the assessment of skin disease in systemic sclerosis? Comment on the article by Kissin et al.
    Kuwahara Y; Shima Y; Kawai M; Hagihara K; Hirano T; Arimitsu J; Narazaki M; Ogata A; Tanaka T; Kawase I; Ogiwara A
    Arthritis Rheum; 2008 Apr; 59(4):601. PubMed ID: 18383411
    [No Abstract]   [Full Text] [Related]  

  • 37. Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: reports of two cases of systemic sclerosis and review of the literature.
    Ughi N; Hervey SA; Gualtierotti R; Silvana Z; Herrick AL; Ingegnoli F; Meroni P
    Semin Arthritis Rheum; 2015 Apr; 44(5):597-601. PubMed ID: 25488380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Musculoskeletal Manifestations of Systemic Sclerosis.
    Morrisroe KB; Nikpour M; Proudman SM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):507-18. PubMed ID: 26210132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Generalized morphea-like progressive systemic sclerosis with anticentromere antibodies and eosinophilic cellulitis].
    Sasaki T; Nakajima H; Kameda Y
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):469-76. PubMed ID: 2614990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
    de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
    Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.